Amgen Ventures focuses on early-stage companies developing human therapeutics in oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, and cardiovascular areas. The firm primarily invests in Series A and B rounds, targeting companies in the United States and Europe. Their investment strategy aligns with Amgen's core mission as a global biopharmaceutical innovator.
Notable portfolio companies include Alector, BeiGene, and Generate Biomedicines. Amgen Ventures leverages its parent company's expertise in biotechnology to provide strategic support and resources to its portfolio companies. This unique positioning allows them to offer valuable insights and potential collaboration opportunities within the broader Amgen ecosystem, enhancing the growth potential of their investments.
Amgen Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments73
Current Portfolio Count44
Total Portfolio Exits1
Top Investment Stages
Series B25 (41.7%)
Series A16 (26.7%)
Series Unknown8 (13.3%)
Series C7 (11.7%)
Seed4 (6.7%)
Stage Mix
Series B 42%Series A 27%Series Unknown 13%Series C 12%Seed 7%
Concentration shown as share of disclosed investments by stage.
Amgen Ventures - Similar Investment Firms
5AM Ventures
5amventures.com
AbbVie Biotech Ventures
abbvie.com
Illumina Ventures
McKesson Ventures
Versant Ventures
Optum Ventures
optumventures.com
Healthcare Ventures
hcven.com
Atlas Venture
atlasventure.com
Asset Management Ventures
assetman.com
Pfizer Venture Investments
pfizer.com
Bioventures Investors
Mass General Brigham Ventures
Amkey Ventures
Nest.Bio Venture
nest.bio
Vida Ventures
vidaventures.com
Amgen Ventures - Classification
- Also Known As
- Amgen Ventures LLC
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 541000Professional, Scientific, and Technical Services
- 523900Other Financial Investment Activities
- 541700Scientific Research and Development Services
- 523990All Other Financial Investment Activities
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- 523999Miscellaneous Financial Investment Activities
- SIC
- 2836Biological Products, Except Diagnostic Substances
- 2800Chemicals And Allied Products
- 6700Holding And Other Investment Offices
- 2830Drugs
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 22 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325414Biological Product (except Diagnostic) Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 525000Funds, Trusts, and Other Financial Vehicles
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 4000Railroad Transportation
- 6000Depository Institutions
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 6720Investment Offices
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 2834Pharmaceutical Preparations
- 6722Management Investment Offices, Open-end
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research